Please try another search
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, develops theranostic therapy and imaging products for the treatment of cancer in children and adults. Its lead product includes SARTATE, a targeted theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express somatostatin receptor 2. The company is also developing SAR-Bombesin, a pan cancer theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express gastrin releasing peptide receptor; and SAR-bisPSMA, a theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express prostate specific membrane antigen. Clarity Pharmaceuticals Ltd was incorporated in 2010 and is based in Sydney, Australia.
Name | Age | Since | Title |
---|---|---|---|
Alan John Taylor | - | 2013 | Executive Chairman |
Christopher Graham Roberts | 69 | 2016 | Non-Executive Director |
Rosanne Elizabeth Robinson | - | 2010 | Independent Non-Executive Director |
Colin David Biggin | - | 2019 | MD, CEO & Executive Director |
Paul Donnelly | - | - | Member of Scientific Advisory Board |
Robert Bain Thomas | 78 | 2021 | Lead Independent Director |
Jason Lewis | - | - | Member of Scientific Advisory Board |
Thomas Ramdahl | 68 | 2019 | Non-Executive Director |
Louise Emmett | - | 2022 | Member of Scientific Advisory Board |
Neal D. Shore | - | 2022 | Member of Scientific Advisory Board |
Oliver Sartor | - | 2020 | Member of Scientific Advisory Board |
Jon Stoner | 67 | 2023 | Member of Scientific Advisory Board |
Andrei Iagaru | - | 2022 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review